ENTITY
HUTCHMED

HUTCHMED (HCM US)

56
Analysis
Health Care • Hong Kong
HUTCHMED is an innovative, commercial-stage biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing targeted therapies and immunotherapies for cancer and immunological diseases. The company has several novel oncology products marketed in China, with one also approved in the US, Europe, and Japan. HUTCHMED was founded in 2000 and is headquartered in Hong Kong.
more
Company Presentation • 03 Sep 2026 19:30

Status update

Company Presentation • 30 Jul 2026 20:00

H1 2026

Company Presentation • 28 Apr 2026 22:00

Deutsche Bank ADR Virtual Investor Conference

Company Presentation • 06 Mar 2026 00:42

H2 2025

Company Presentation • 04 Nov 2025 21:00

Deutsche Bank ADR Virtual Investor Conference 2025

x